featured
Tixagevimab–Cilgavimab for Treatment of Patients Hospitalised With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
Lancet Respir Med 2022 Jul 08;[EPub Ahead of Print], TL Holland, AA Ginde, R Paredes, TA Murray, N Engen, G Grandits, A Vekstein, N Ivey, A Mourad, U Sandkovsky, RL Gottlieb, M Berhe, MK Jain, R Marines-Price, B Tchamba Agbor Agbor, L Mateu, S España-Cueto, G Lladós, E Mylonakis, R Rogers, F Shehadeh, MR Filbin, KA Hibbert, K Kim, T Tran, PE Morris, EP Cassity, B Trautner, LM Pandit, KU Knowlton, L Leither, MA Matthay, AJ Rogers, W Drake, B Jones, G Poulakou, KN Syrigos, E Fernández-Cruz, M Di Natale, E Almasri, L Balerdi-Sarasola, SR Bhagani, KL Boyle, JD Casey, P Chen, DJ Douin, DC Files, HF Günthard, RD Hite, RC Hyzy, A Khan, M Kibirige, R Kidega, I Kimuli, F Kiweewa, J-U Jensen, BG Leshnower, JK Lutaakome, P Manian, JL Morales-Rull, DS O’Mahony, JS Overcash, S Ramachandruni, JS Steingrub, HS Taha, M Waters, BE Young, AN Phillips, DD Murray, TO Jensen, ML Padilla, D Sahner, K Shaw-Saliba, RL Dewar, M Teitelbaum, V Natarajan, MT Rehman, S Pett, F Hudson, G Touloumi, SM Brown, WH Self, CC Chang, A Sánchez, AC Weintrob, T Hatlen, B Grund, S Sharma, CS Reilly, P Garbes, MT Esser, A Templeton, AG Babiker, VJ Davey, AC Gelijns, ES Higgs, V Kan, G Matthews, BT Thompson, JD Neaton, C Lane, JD LundgrenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.